Related Experiment Video

Updated: Jul 5, 2026

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

Pediatric headache

Paul Winner1

  • 1Palm Beach Headache Center, Nova Southeastern University, West Palm Beach, Florida 33407, USA. eneuro@aol.com

Current Opinion in Neurology
|May 3, 2008
PubMed

Insights

Pediatric migraine is increasingly common and impacts families significantly. This review covers updated diagnostic criteria, new treatments, and management strategies for better recognition and care of headaches in children.

Area of Science:

  • Neurology
  • Pediatrics
  • Headache Medicine

Background:

  • Headaches are prevalent in children, significantly affecting patients and families.
  • Migraine, a common reason for pediatric physician visits, is often underdiagnosed and undertreated.
  • Recent data indicate a rising incidence of migraine and chronic migraine in pediatric populations.

Purpose of the Study:

  • To present limitations in current migraine diagnostic criteria and propose modifications for earlier recognition and treatment.
  • To review new data on acute and preventive migraine treatments with statistically significant benefits.
  • To discuss the clinical impact of migraine on pediatric patients using validated assessment tools.

Main Methods:

  • Review of current diagnostic criteria for pediatric migraine.
  • Analysis of recent clinical trial data for acute and preventive migraine therapies.
  • Evaluation of patient-reported outcome measures for pediatric migraine disability and quality of life.

Main Results:

  • Proposed modifications to diagnostic criteria may improve early migraine recognition in children.
  • New acute and preventive treatments demonstrate statistically significant efficacy.
  • Validated instruments show the significant clinical impact of migraine on pediatric patients' lives.

Conclusions:

  • A comprehensive management strategy integrating acute, preventive, and biobehavioral treatments is recommended.
  • Further research with novel designs is needed to understand pediatric headache pathophysiology and improve diagnostic criteria.
  • Prospective studies are essential to evaluate preventive management efficacy and the benefits of early intervention in slowing disease progression.
Abstract

More Related Videos

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...